Oral Corticosteroid Dosing for Rheumatoid Arthritis Flare

Initial Dosing Considerations

The recommended oral corticosteroid dose for rheumatoid arthritis flares is 12.5-25 mg of prednisone daily, with the specific dose within this range determined by the patient's risk profile for side effects and relapse 1
Higher initial doses within the 12.5-25 mg range are appropriate for patients with high risk of relapse and low risk of adverse events 1
Lower initial doses within this range should be used for patients with relevant comorbidities such as diabetes, osteoporosis, or glaucoma 1
Initial doses ≤7.5 mg/day are discouraged and doses >30 mg/day are strongly recommended against 1

After achieving symptom control, reduce the dose gradually to 10 mg/day within 4-8 weeks 2, 1
Once remission is maintained, taper prednisone by 1 mg every 4 weeks until discontinuation 1

For patients with frequent relapses or prolonged therapy needs, consider adding methotrexate as a corticosteroid-sparing agent 3, 1
Intramuscular methylprednisolone can be considered as an alternative to oral glucocorticoids in select patients 1

If insufficient improvement occurs within 2 weeks, consider increasing the oral dose up to 25 mg prednisone 2
For patients who relapse while on treatment, increase prednisone to the pre-relapse dose and then decrease gradually to the dose at which relapse occurred 3, 1

Follow patients every 4-8 weeks during the first year of treatment 2, 1
Monitor inflammatory markers and clinical symptoms to assess treatment response 3
Systematically evaluate for corticosteroid-related adverse effects, particularly bone mineral density 1